The ongoing COVID-19 pandemic continues to impose demands on diagnostic screening. With the resurgence of outbreaks, one-step, one enzyme approaches to reverse transcription polymerase chain..

SEKISUI Diagnostics’ National Accounts Director, Jonathan Overbey talks with Ian Fardy from National Distribution and Contracting about the current state and what we can expect from the upcoming..

Early detection of cancer saves lives. It is challenging, even in the best of times, to keep patients up to date on screening for certain conditions such as colon cancer, bowel cancer, and..